These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17273972)

  • 1. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions.
    Zweier C; Sticht H; Aydin-Yaylagül I; Campbell CE; Rauch A
    Am J Hum Genet; 2007 Mar; 80(3):510-7. PubMed ID: 17273972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic variability of atypical 22q11.2 deletions not including TBX1.
    Verhagen JM; Diderich KE; Oudesluijs G; Mancini GM; Eggink AJ; Verkleij-Hagoort AC; Groenenberg IA; Willems PJ; du Plessis FA; de Man SA; Srebniak MI; van Opstal D; Hulsman LO; van Zutven LJ; Wessels MW
    Am J Med Genet A; 2012 Oct; 158A(10):2412-20. PubMed ID: 22893440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TBX1 in human del22q11.2 syndrome.
    Yagi H; Furutani Y; Hamada H; Sasaki T; Asakawa S; Minoshima S; Ichida F; Joo K; Kimura M; Imamura S; Kamatani N; Momma K; Takao A; Nakazawa M; Shimizu N; Matsuoka R
    Lancet; 2003 Oct; 362(9393):1366-73. PubMed ID: 14585638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel TBX1 loss-of-function mutation causes isolated conotruncal heart defects in Chinese patients without 22q11.2 deletion.
    Xu YJ; Chen S; Zhang J; Fang SH; Guo QQ; Wang J; Fu QH; Li F; Xu R; Sun K
    BMC Med Genet; 2014 Jul; 15():78. PubMed ID: 24998776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel nuclear localization signal in Tbx1 that is deleted in DiGeorge syndrome patients harboring the 1223delC mutation.
    Stoller JZ; Epstein JA
    Hum Mol Genet; 2005 Apr; 14(7):885-92. PubMed ID: 15703190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TBX1 mutation identified by exome sequencing in a Japanese family with 22q11.2 deletion syndrome-like craniofacial features and hypocalcemia.
    Ogata T; Niihori T; Tanaka N; Kawai M; Nagashima T; Funayama R; Nakayama K; Nakashima S; Kato F; Fukami M; Aoki Y; Matsubara Y
    PLoS One; 2014; 9(3):e91598. PubMed ID: 24637876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic and clinical characteristics of 22q11.2 deletion syndrome].
    Kozlova IuO; Zabnenkova VV; Shilova NV; Min'zhenkova ME; Antonenko VG; Kotlukova NP; Simonova LV; Kazanceva IA; Levchenko EG; Bombardirova TD; Zolotukhina TV; Poliakov AV
    Genetika; 2014 May; 50(5):602-10. PubMed ID: 25715476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in TBX1 genocopy the 22q11.2 deletion and duplication syndromes: a new susceptibility factor for mental retardation.
    Torres-Juan L; Rosell J; Morla M; Vidal-Pou C; García-Algas F; de la Fuente MA; Juan M; Tubau A; Bachiller D; Bernues M; Perez-Granero A; Govea N; Busquets X; Heine-Suñer D
    Eur J Hum Genet; 2007 Jun; 15(6):658-63. PubMed ID: 17377518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the role of Tbx1 as a candidate gene for 22q11.2 deletion syndrome.
    Gao S; Li X; Amendt BA
    Curr Allergy Asthma Rep; 2013 Dec; 13(6):613-21. PubMed ID: 23996541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of a gene from the DiGeorge chromosomal region homologous to the mouse Tbx1 gene.
    Chieffo C; Garvey N; Gong W; Roe B; Zhang G; Silver L; Emanuel BS; Budarf ML
    Genomics; 1997 Aug; 43(3):267-77. PubMed ID: 9268629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome.
    Paylor R; Glaser B; Mupo A; Ataliotis P; Spencer C; Sobotka A; Sparks C; Choi CH; Oghalai J; Curran S; Murphy KC; Monks S; Williams N; O'Donovan MC; Owen MJ; Scambler PJ; Lindsay E
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7729-34. PubMed ID: 16684884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of TBX1 dosage in the anterior heart field results in congenital heart disease resembling the 22q11.2 duplication syndrome.
    Hasten E; McDonald-McGinn DM; Crowley TB; Zackai E; Emanuel BS; Morrow BE; Racedo SE
    Hum Mol Genet; 2018 Jun; 27(11):1847-1857. PubMed ID: 29509905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical deletion of 22q11.2: detection using the FISH TBX1 probe and molecular characterization with high-density SNP arrays.
    Beaujard MP; Chantot S; Dubois M; Keren B; Carpentier W; Mabboux P; Whalen S; Vodovar M; Siffroi JP; Portnoï MF
    Eur J Med Genet; 2009; 52(5):321-7. PubMed ID: 19467348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel TBX1 missense mutation in patients with syndromic congenital heart defects.
    Jaouadi A; Tabebi M; Abdelhedi F; Abid D; Kamoun F; Chabchoub I; Maatoug S; Doukali H; Belghuith N; Ksentini MA; Keskes LA; Triki C; Hachicha M; Kamoun S; Kamoun H
    Biochem Biophys Res Commun; 2018 May; 499(3):563-569. PubMed ID: 29596833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.
    Guo T; McDonald-McGinn D; Blonska A; Shanske A; Bassett AS; Chow E; Bowser M; Sheridan M; Beemer F; Devriendt K; Swillen A; Breckpot J; Digilio MC; Marino B; Dallapiccola B; Carpenter C; Zheng X; Johnson J; Chung J; Higgins AM; Philip N; Simon TJ; Coleman K; Heine-Suner D; Rosell J; Kates W; Devoto M; Goldmuntz E; Zackai E; Wang T; Shprintzen R; Emanuel B; Morrow B;
    Hum Mutat; 2011 Nov; 32(11):1278-89. PubMed ID: 21796729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH.
    Bittel DC; Yu S; Newkirk H; Kibiryeva N; Holt A; Butler MG; Cooley LD
    Cytogenet Genome Res; 2009; 124(2):113-20. PubMed ID: 19420922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 22q11.2 deletion syndrome: a gene dosage perspective.
    Baldini A
    ScientificWorldJournal; 2006 May; 6():1881-7. PubMed ID: 17205194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advance of research on 22q11.2 deletion syndrome].
    Zhou H; Weng X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Aug; 41(8):994-1000. PubMed ID: 39097286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility gene card for: DiGeorge syndrome, velocardiofacial syndrome, Shprintzen syndrome, chromosome 22q11.2 deletion syndrome (22q11.2, TBX1).
    Schwinger E; Devriendt K; Rauch A; Philip N
    Eur J Hum Genet; 2010 Sep; 18(9):. PubMed ID: 20125192
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR).
    McQuade L; Christodoulou J; Budarf M; Sachdev R; Wilson M; Emanuel B; Colley A
    Am J Med Genet; 1999 Sep; 86(1):27-33. PubMed ID: 10440825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.